Micron Biomedical

Atlanta, United States Founded: 2014 • Age: 12 yrs
Microneedle patches are developed for vaccine and drug delivery.
Annual revenue - Latest available
Total funding $33.0M 5 rounds
Employees 11 Tracked headcount
Investors 9 Known backers
Products 2 Services tracked
Competitors 8 Brand Intelligence

About Micron Biomedical

Micron Biomedical is a company based in Atlanta (United States) founded in 2014. Micron Biomedical has raised $33 million across 5 funding rounds from investors including UNICEF, Centers for Disease Control and Prevention and Gates Foundation. The company has 11 employees as of December 31, 2021. Micron Biomedical offers products and services including Dissolvable Microarray Technology and Thermostable Vaccine Delivery. Micron Biomedical operates in a competitive market with competitors including Enable Injections, Zosano Pharma, SkinJect, Raphas and STM, among others.

  • Headquarter Atlanta, United States
  • Employees 11 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Micron Biomedical, Inc.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $33 M (USD)

    in 5 rounds

  • Latest Funding Round
    $2 M (USD), Grant

    Jan 14, 2025

  • Investors
    UNICEF

    & 8 more

  • Employee Count
    11

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Micron Biomedical

Micron Biomedical offers a comprehensive portfolio of products and services, including Dissolvable Microarray Technology and Thermostable Vaccine Delivery.

Product name locked
Category locked
Primary

Enables needle-free administration of vaccines and therapeutics globally.

Product name locked
Category locked
Locked

Provides stable, needle-free solutions for vaccine distribution and use.

People of Micron Biomedical

Headcount 1-10
Employee Profiles 5
Employee Profiles
People
Steve Damon
Chief Executive Officer
People
Idean Marvasty
Chief Financial Officer
People
Winston Pewin
Principal Development Engineer
People
Stephanie Adams
Director, Intellectual Property & Grants

Unlock access to complete

Funding Insights of Micron Biomedical

Micron Biomedical has successfully raised a total of $33M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $2 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Micron Biomedical

Micron Biomedical has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include UNICEF, Centers for Disease Control and Prevention and Gates Foundation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments in tech startups are made by J2 Ventures.
Locked Locked Locked
Seed & early stage sector-agnostic venture capital firm funding companies in the US
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Premium access

Investor details for Micron Biomedical

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Micron Biomedical

Investments
Premium access

Investment portfolio details for Micron Biomedical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Micron Biomedical

Premium access

Detailed financials for Micron Biomedical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Micron Biomedical Comparisons

Micron Biomedical Primary company
Description
Microneedle patches are developed for vaccine and drug deliv...
Location
Atlanta, United States
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
11
As of 2021
Premium access

Peer comparison for Micron Biomedical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Micron Biomedical

Micron Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enable Injections, Zosano Pharma, SkinJect, Raphas and STM, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of a wearable drug delivery solution
Locked Locked Locked
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
Locked Locked Locked
Dissolvable microneedle patches for non-melanoma skin cancer treatment are developed.
Locked Locked Locked
Microneedle technology is developed for cosmetics and medical applications.
Locked Locked Locked
Transdermal patches for painless vaccine delivery via microneedles are developed.
Premium access

Detailed competitors of Micron Biomedical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Micron Biomedical

Premium access

Complete news archive for Micron Biomedical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Micron Biomedical

Micron Biomedical was founded in 2014 and raised its 1st funding round 8 years after it was founded.

Micron Biomedical is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.

Micron Biomedical is a funded company, having raised a total of $33M across 5 funding rounds to date.

As of Dec 31, 2021, the latest employee count at Micron Biomedical is 11.

Micron Biomedical was founded in 2014 in Atlanta, United States, within the biomedical sector. Focus is placed on microneedle patch technology that enables minimally invasive delivery of vaccines and drugs. The patches penetrate upper skin layers and dissolve quickly, supporting targeted therapeutic applications. Operations center on advancing this delivery method for improved efficacy in healthcare settings.

Micron Biomedical's top competitors include Enable Injections, SkinJect and Raphas.

Micron Biomedical offers Dissolvable Microarray Technology and Thermostable Vaccine Delivery.

Micron Biomedical has 9 investors. Key investors include UNICEF, Centers for Disease Control and Prevention, Gates Foundation, HHS, and Path.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available